MarketPulse
T

$TATT

1 article found
0 positive
1 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Johnson Fistel, Pllp

Johnson Fistel Investigates Viridian Therapeutics Over Phase 3 Trial Disclosure

Johnson Fistel investigates Viridian Therapeutics for potential securities law violations related to Phase 3 REVEAL-1 trial disclosures, offering shareholders potential loss recovery options.
VRDNBAKTATTsecurities fraudinvestor losses